cognitive neuroscience

Posted by munosib on August 28th, 2019

cognitive neuroscience

Groundbreaking cognitive neuroscience research has occurred over the last 20 years - without parallel growth of consumer awareness and appropriate professional dissemination. "Cognition" remains an elusive concept with unclear implications outside the research community.

Earlier this year, I presented a talk to health care professionals at the New York Academy of Medicine, titled "Brain Fitness Software: Helping Consumers Separate Hope from Hype". I explained what computerized cognitive assessment and training tools can do (assess/enhance specific cognitive functions), what they cannot do (reduce one's "brain age") and the current uncertainties about what they can do (i.e., delay Alzheimer's symptoms). At the same symposium, Dr. Gary Kennedy, Director of Geriatric Psychiatry at Montefiore Medical Center, provided guidance on why and how to screen for executive function deficits in the context of dementia.

I could perceive two emerging trends at the event: 1) "Augmenting Cognition" research is most commonly framed as a healthcare, often pharmacological topic, with the traditional cognitive bias in medicine of focusing on detection and treatment of disease, 2) In addition, there is a growing interest in non-invasive enhancement options and overall lifestyle issues. Research findings in Augmenting Cognition are only just beginning to reach the mainstream marketplace, mostly through healthcare channels. The opportunity is immense, but we will need to ensure the marketplace matures in a rational and sustainable manner, both through healthcare and non-healthcare channels.